Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function.
Animals
Mice
Class III Phosphatidylinositol 3-Kinases
/ metabolism
Male
Prostatic Neoplasms
/ drug therapy
Vitamin K 3
/ pharmacology
Protein Tyrosine Phosphatases, Non-Receptor
/ metabolism
Humans
Oxidation-Reduction
Oxidants
/ metabolism
Longevity
/ drug effects
Dietary Supplements
Cysteine
/ metabolism
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
25 Oct 2024
25 Oct 2024
Historique:
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
24
10
2024
Statut:
ppublish
Résumé
Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show that a pro-oxidant vitamin K precursor [menadione sodium bisulfite (MSB)] suppresses PC progression in mice, killing cells through an oxidative cell death: MSB antagonizes the essential class III phosphatidylinositol (PI) 3-kinase VPS34-the regulator of endosome identity and sorting-through oxidation of key cysteines, pointing to a redox checkpoint in sorting. Testing MSB in a myotubular myopathy model that is driven by loss of
Identifiants
pubmed: 39446948
doi: 10.1126/science.adk9167
doi:
Substances chimiques
Class III Phosphatidylinositol 3-Kinases
EC 2.7.1.137
Vitamin K 3
723JX6CXY5
Protein Tyrosine Phosphatases, Non-Receptor
EC 3.1.3.48
PIK3C3 protein, mouse
EC 2.7.1.137
Oxidants
0
Cysteine
K848JZ4886
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
eadk9167Commentaires et corrections
Type : CommentIn